ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
50 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
26K
|
13M
|
50
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
50 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
26K
|
13M
|
50
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Specyray
|
324 |
106K |
20 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
324
|
106K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
39 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
26K
|
13M
|
39
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
132 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
26K
|
13M
|
132
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
139 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
26K
|
13M
|
139
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
169 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
26K
|
13M
|
169
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
182 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
26K
|
13M
|
182
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
|
|
Specyray
|
506 |
233K |
49 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
506
|
233K
|
49
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
101 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
26K
|
13M
|
101
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
12 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
26K
|
13M
|
12
|
|
ASX - By Stock
|
IMU |
The most appreciated poster ever
|
|
Specyray
|
7 |
4.7K |
164 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
7
|
4.7K
|
164
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Corporate Presentation
|
|
Specyray
|
246 |
117K |
139 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
246
|
117K
|
139
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Specyray
|
15K |
7.4M |
11 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
15K
|
7.4M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Specyray
|
15K |
7.4M |
5 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
15K
|
7.4M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
68 |
06/05/23 |
06/05/23 |
ASX - By Stock
|
26K
|
13M
|
68
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
157 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
26K
|
13M
|
157
|
|
ASX - By Stock
|
IMU |
Re:
Competitive landscape
|
|
Specyray
|
244 |
117K |
85 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
244
|
117K
|
85
|
|
ASX - By Stock
|
IMU |
Re:
Hervaxx Trials
|
|
Specyray
|
63 |
41K |
45 |
28/01/23 |
28/01/23 |
ASX - By Stock
|
63
|
41K
|
45
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
9 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
26K
|
13M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
11 |
01/01/23 |
01/01/23 |
ASX - By Stock
|
26K
|
13M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
13 |
31/12/22 |
31/12/22 |
ASX - By Stock
|
26K
|
13M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
28 |
31/12/22 |
31/12/22 |
ASX - By Stock
|
26K
|
13M
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
18 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
26K
|
13M
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
17 |
23/10/22 |
23/10/22 |
ASX - By Stock
|
26K
|
13M
|
17
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Specyray
|
887 |
350K |
11 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
887
|
350K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Paul Hopper IP opportunists CHM VS RAD
|
|
Specyray
|
15 |
7.8K |
11 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
15
|
7.8K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
Specyray
|
380 |
180K |
9 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
380
|
180K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Cell therapy industry leader appointed Chief Medical Officer
|
|
Specyray
|
10 |
3.9K |
11 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
10
|
3.9K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
Specyray
|
380 |
180K |
13 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
380
|
180K
|
13
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
Specyray
|
380 |
180K |
9 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
380
|
180K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
Specyray
|
380 |
180K |
11 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
380
|
180K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
Specyray
|
380 |
180K |
8 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
380
|
180K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
34 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
26K
|
13M
|
34
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Licenses viral vector technology from Penn for CDH17
|
|
Specyray
|
30 |
12K |
18 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
30
|
12K
|
18
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib
|
|
Specyray
|
30 |
10K |
18 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
30
|
10K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
37 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
26K
|
13M
|
37
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib
|
|
Specyray
|
30 |
10K |
14 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
30
|
10K
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Ann: A$30 million Equity Placement Agreement with L1 Capital
|
|
Specyray
|
43 |
17K |
5 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
43
|
17K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
14 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
26K
|
13M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Specyray
|
26K |
13M |
13 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
26K
|
13M
|
13
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Specyray
|
887 |
350K |
5 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
887
|
350K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Specyray
|
887 |
350K |
9 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
887
|
350K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Specyray
|
15K |
7.4M |
47 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
15K
|
7.4M
|
47
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Specyray
|
15K |
7.4M |
26 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
15K
|
7.4M
|
26
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Specyray
|
15K |
7.4M |
18 |
12/05/22 |
12/05/22 |
ASX - By Stock
|
15K
|
7.4M
|
18
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
Specyray
|
380 |
180K |
10 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
380
|
180K
|
10
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Further Technical Update
|
|
Specyray
|
52 |
25K |
2 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
52
|
25K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
valuation thoughts
|
|
Specyray
|
380 |
180K |
13 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
380
|
180K
|
13
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Specyray
|
887 |
350K |
3 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
887
|
350K
|
3
|
|